Profile data is unavailable for this security.
About the company
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
- Revenue in CAD (TTM)0.00
- Net income in CAD-38.93m
- Incorporated2001
- Employees--
- LocationSernova Corp700 Collip Circle, Ste 114LONDON N6G 4X8CanadaCAN
- Phone+1 (519) 858-5126
- Fax+1 (519) 858-5126
- Websitehttps://www.sernova.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Conavi Medical Corp | 1.33m | -7.06m | 40.71m | 4.00 | -- | 27.47 | -- | 30.62 | -0.0621 | -0.0621 | 0.0113 | 0.0335 | 0.1094 | -- | -- | 332,405.00 | -58.12 | -113.26 | -82.14 | -793.56 | -- | -- | -531.26 | -201.89 | -- | -- | 0.2869 | -- | -- | -- | 116.34 | -- | -12.72 | -- |
| Perimeter Medical Imaging AI Inc | 704.81k | -15.64m | 41.09m | -- | -- | 2.10 | -- | 58.29 | -0.2411 | -0.2411 | 0.0109 | 0.2094 | 0.0248 | 2.04 | 2.97 | -- | -55.09 | -64.55 | -75.24 | -81.45 | 54.10 | -- | -2,218.59 | -7,957.25 | 3.61 | -- | 0.0169 | -- | 203.93 | -- | -41.69 | -- | -- | -- |
| Nanalysis Scientific Corp | 39.47m | -12.93m | 42.41m | 130.00 | -- | 1.75 | -- | 1.07 | -0.1273 | -0.1273 | 0.3847 | 0.2137 | 0.6372 | 4.70 | 5.80 | 303,630.80 | -20.87 | -18.30 | -29.36 | -25.35 | 22.58 | 42.75 | -32.75 | -39.01 | 1.03 | -1.54 | 0.4177 | -- | 14.69 | 27.71 | -63.35 | -- | 15.35 | -- |
| Medmira Inc | 383.32k | -3.11m | 57.66m | 65.00 | -- | -- | -- | 150.43 | -0.0045 | -0.0045 | 0.0006 | -0.024 | 0.0752 | 0.7431 | 0.2848 | -- | -61.10 | -69.95 | -- | -- | 62.61 | 66.76 | -812.38 | -187.61 | 0.2112 | -1.96 | -- | -- | -54.57 | -5.98 | -46.08 | -- | -- | -- |
| Theralase Technologies Inc | 920.62k | -4.41m | 63.60m | 0.00 | -- | 41.15 | -- | 69.08 | -0.0195 | -0.0195 | 0.0041 | 0.0069 | 0.2722 | 0.767 | 2.65 | -- | -130.29 | -69.79 | -204.79 | -81.78 | 49.00 | 37.49 | -478.72 | -557.68 | 0.7723 | -- | 0.1707 | -- | -6.00 | -9.20 | 12.69 | -- | -22.53 | -- |
| Sernova Corp | 0.00 | -38.93m | 74.82m | -- | -- | -- | -- | -- | -0.1283 | -0.1283 | 0.00 | -0.0413 | 0.00 | -- | -- | -- | -191.48 | -74.84 | -693.32 | -85.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -59.69 | -- | -2.91 | -- |
| Covalon Technologies Ltd | 29.20m | -823.40k | 97.26m | -- | -- | 4.04 | 773.53 | 3.33 | -0.0335 | -0.0335 | 1.18 | 0.8786 | 1.10 | 1.77 | 5.15 | -- | -3.11 | -18.06 | -3.72 | -27.10 | 56.45 | 51.89 | -2.82 | -27.06 | 3.72 | -21.12 | 0.0474 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
